» Articles » PMID: 17308975

Resveratrol in Cell Fate Decisions

Overview
Publisher Springer
Date 2007 Feb 20
PMID 17308975
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol, a polyphenolic phytoalexin, is one of the most extensively studied natural products, with wide ranging biological activity and tremendous clinical potential. First identified from fruits and plants, in particular grapes and wines, its positive effects on a variety of disease states have been unraveled over the past decade or so. Most noticeable are its anti-thrombogenic, anti-inflammatory, cardio-protective, neuro-protective, anti-aging, and cancer preventive and therapeutic activities. Recent data also indicate that depending upon the concentration/dose, resveratrol can trigger or block cell death signaling in tumor cells. Considering the heightened interest in this compound, here we present a short review on the biological activity of this remarkable compound, with a specific focus on its effects on cell survival and death signals.

Citing Articles

Biosynthesis of resveratrol by an endophytic Priestia megaterium PH3 via the phenylpropane pathway.

Zhang X, Zhang D, Ding Y, Li Z, Wang C, Ye S Appl Microbiol Biotechnol. 2023; 107(24):7581-7599.

PMID: 37801099 DOI: 10.1007/s00253-023-12768-x.


Sodium-calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer's disease.

Afewerky H, Li H, Zhang T, Li X, Mahaman Y, Duan L Sci Rep. 2022; 12(1):1537.

PMID: 35087161 PMC: 8795410. DOI: 10.1038/s41598-022-05568-2.


Long-term dietary resveratrol supplementation decreased serum lipids levels, improved intramuscular fat content, and changed the expression of several lipid metabolism-related miRNAs and genes in growing-finishing pigs1.

Zhang H, Chen D, He J, Zheng P, Yu J, Mao X J Anim Sci. 2019; 97(4):1745-1756.

PMID: 30852606 PMC: 6447270. DOI: 10.1093/jas/skz057.


Neuroprotection in Glaucoma: Old and New Promising Treatments.

Rusciano D, Pezzino S, Mutolo M, Giannotti R, Librando A, Pescosolido N Adv Pharmacol Sci. 2019; 2017:4320408.

PMID: 30723498 PMC: 5664381. DOI: 10.1155/2017/4320408.


Rational Basis for Nutraceuticals in the Treatment of Glaucoma.

Morrone L, Rombola L, Adornetto A, Corasaniti M, Russo R Curr Neuropharmacol. 2017; 16(7):1004-1017.

PMID: 29119928 PMC: 6120110. DOI: 10.2174/1570159X15666171109124520.


References
1.
Pervaiz S . Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat. 2005; 7(6):333-44. DOI: 10.1016/j.drup.2004.11.001. View

2.
Ying W . NAD+ and NADH in cellular functions and cell death. Front Biosci. 2006; 11:3129-48. DOI: 10.2741/2038. View

3.
Baur J, Sinclair D . Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5(6):493-506. DOI: 10.1038/nrd2060. View

4.
Wang Y, Wang B, Cheng J, Yang L, Liu Z, Balan K . FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochem Pharmacol. 2005; 69(2):249-54. DOI: 10.1016/j.bcp.2004.09.013. View

5.
Ou H, Chou F, Sheen H, Lin T, Yang C, Sheu W . Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chim Acta. 2005; 364(1-2):196-204. DOI: 10.1016/j.cccn.2005.06.018. View